Polymer-Free Organo-Modified Clay Films for Drug Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing clay composite sheets for wound dressings and drug delivery require polymer additives, which can hinder the permeation of moisture and chemicals, and do not provide a continuous path for drug diffusion, limiting their effectiveness in antimicrobial and transdermal applications.
Innovation Solution
Development of polymer-free organo-modified clay products using montmorillonite, kaolinite, or bentonite clay with organic compounds like betaine or silver ions, formed into thin films or sheets without the use of polymers, to create flexible, antimicrobial, and analgesic wound dressings that allow for controlled drug delivery and enhanced wound healing.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Strength
If polymer additives are used in clay composite sheets, then mechanical stability and structural integrity are improved, but permeation of moisture and chemicals is hindered, and continuous drug diffusion path is blocked
Solution Approach 1:
The patent removes polymer additives from the clay composite sheet formulation, extracting the harmful element that blocked permeation while maintaining structural integrity through alternative means (clay particle networking and organic compound modification). This resolves the contradiction by eliminating the source of the permeation barrier while preserving mechanical stability through the modified clay structure itself.
Solution Approach 2:
The patent modifies the clay particles through organic compound treatment, changing their surface properties and interparticle interactions. This parameter change allows clay particles to self-assemble into a stable, continuous matrix that provides both mechanical strength and permeability pathways, replacing the need for polymer additives while enabling drug diffusion.
2Ease of manufacture
If clay particles are used in particulate form, then ease of manufacture is improved, but continuous film formation is prevented, blocking drug diffusion path
Solution Approach 1:
The patent applies organic compounds to modify clay particle surfaces, changing their wettability, surface charge, and interparticle forces. These parameter changes enable particulate clay to self-organize into continuous films during processing, bridging the gap between ease of manufacture with particles and the need for continuous film structure for drug diffusion.
Solution Approach 2:
The patent creates a composite structure where organic compounds are integrated with clay particles to form a hybrid material system. This composite approach allows the combination of particle-based manufacturability with film-like continuous structure, as the organic-modified particles self-assemble into a cohesive, permeable matrix suitable for transdermal drug delivery.
3Strength
If polymer-clay composites are used, then mechanical resistance is improved, but chemical stability and controlled drug release are compromised due to dose dumping
Solution Approach 1:
The patent removes polymer components from the composite system, eliminating the source of chemical instability and dose dumping. The resulting polymer-free clay composite maintains mechanical resistance through optimized clay particle arrangements and organic modifications, while achieving superior chemical stability and controlled drug release characteristics.
Solution Approach 2:
The patent modifies clay particle properties through organic compound treatment, changing surface chemistry, pore structure, and drug interaction characteristics. These parameter changes enable the clay matrix to provide both mechanical strength and controlled drug release, replacing polymer functions with clay-based mechanisms that offer better chemical stability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The polymer-free organo-modified clay products achieve high flexibility, antimicrobial efficacy, and controlled drug release, effectively addressing the limitations of polymer-based composites by providing a continuous diffusion path and enhanced wound healing properties without the drawbacks of polymer additives.
Implementation Method 1
Clay minerals are naturally occurring inorganic cationic exchangers and so they can undergo ion exchange with basic drugs in solution
Implementation Method 2
organic molecules can bond to clays via physical adsorption and ion-dipole interactions of acidic and nonionized molecules
Implementation Method 3
there does not exist a continuous path for drugs to diffuse from the clay particles to wound or skin surface
Data Source
Figure 1(A)~1(C)
Figure 2a~2d
Figure 3
AI summary
Clay composite sheets, mats, films or membranes without polymers. Methods of preparing clay composite sheets, mats, films or membranes without using polymers in the method. Methods of using clay composite sheets, mats, films or membranes prepared without using polymers. Antimicrobial dressing having organo-modified clay product. Transdermal delivery of drugs using organo- modified clay product and methods.